GE Healthcare Investor Presentation — January 2018

Document content

Kieran Murphy, President & CEO

Confidential. Not to be copied, reproduced, or distributed without prior approval.

CAUTION CONCERNING FORWARD -LOOKING STATEMENTS:

This document contains "forward -looking statements" –that is, statements related to future events

that by their nature address matters that are, to different degrees, uncertain. For details

on the uncertainties that may cause our actual future results to be materially different than those

expressed in our forward -looking statements, see

http://www.ge.com/investor -relations/disclaimer -caution -concerning -forwardlooking -statements as

well as our annual reports on Form 10 -K and quarterly reports on Form 10 -Q. We do not undertake

to update our forward -looking statements. This document also includes certain forward -looking

projected financial information that is based on current estimates and

forecasts. Actual results could differ materially. This is GE Healthcare

managementBiologics and

‘17 3Q YTDRevenue Op Profit OP% FCF Conv.

9 January 2018 2Leader in Imaging &

Mobile DiagnosticsLeader in China and

Emerging MarketsLeader in Data

and AnalyticsLeader in

> 100%Placeholder confidentiality disclosure. Edit or delete from master slide if not needed.DIAGNOSTIC IMAGING

& SERVICEIT & DIGITAL

& MONITORINGLIFE SCIENCES

A leading healthcare solutions provider

9 January 2018 3Magnetic Resonance

Service & SolutionsEnterprise Imaging